Free Access
Med Sci (Paris)
Volume 29, Number 12, Décembre 2013
Page(s) 1111 - 1116
Section M/S Revues
Published online 20 December 2013
  1. Stein DJ. Obsessive-compulsive disorder. Lancet 2002 ; 360 : 397–405. [CrossRef] [PubMed] [Google Scholar]
  2. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National comorbidity survey replication. Arch Gen Psychiatry 2005 ; 62 : 593–602. [CrossRef] [PubMed] [Google Scholar]
  3. Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet 2009 ; 374 : 491–499. [CrossRef] [PubMed] [Google Scholar]
  4. Taylor S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin Psychol Rev 2011 ; 31 : 1083–1100. [CrossRef] [PubMed] [Google Scholar]
  5. Katerberg H, Delucchi KL, Stewart SE, et al. Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet 2010 ; 40 : 505–517. [CrossRef] [PubMed] [Google Scholar]
  6. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross national collaborative group. J Clin Psychiatry 1994 ; 55 : suppl 5–10. [Google Scholar]
  7. Pallanti S. Transcultural observations of obsessive-compulsive disorder. Am J Psychiatry 2008 ; 165 : 169–170. [CrossRef] [PubMed] [Google Scholar]
  8. Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci 2010 ; 12 : 149–163. [PubMed] [Google Scholar]
  9. Welch JM, Lu J, Rodriguiz RM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007 ; 448 : 894–900. [CrossRef] [PubMed] [Google Scholar]
  10. Nestadt G, Grados M, Samuels JF. Genetics of obsessive-compulsive disorder. Psychiatr Clin North Am 2010 ; 33 : 141–158. [CrossRef] [PubMed] [Google Scholar]
  11. Rotge JY, Aouizerate B, Tignol J, et al. The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms. Neuroscience 2010 ; 165 : 408–417. [CrossRef] [PubMed] [Google Scholar]
  12. De Leeuw AS, Westenberg HGM. Hypersensitivity of 5-HT2 receptors in OCD patients. J Psychiatr Res 2008 ; 42 : 894–901. [CrossRef] [PubMed] [Google Scholar]
  13. Chakrabarty K, Bhattacharyya S, Christopher R, et al. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 2005 ; 30 : 1735–1740. [CrossRef] [PubMed] [Google Scholar]
  14. MacMaster FP, O’Neill J, Rosenberg DR. Brain imaging in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008 ; 47 : 1262–1272. [CrossRef] [PubMed] [Google Scholar]
  15. Haynes WIA, Mallet L. High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit. Eur J Neurosci 2010 ; 32 : 1118–1127. [CrossRef] [PubMed] [Google Scholar]
  16. Taj MJRJ, Viswanath B, Purushottam M, et al. DRD4 gene and obsessive compulsive disorder: Do symptom dimensions have specific genetic correlates? Prog Neuropsychopharmacol Biol Psychiatry 2013 ; 41 : 18–23. [CrossRef] [PubMed] [Google Scholar]
  17. Aouizerate B, Guehl D, Cuny E, et al. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 2004 ; 72 : 195–221. [CrossRef] [PubMed] [Google Scholar]
  18. Murphy TK, Storch EA, Lewin AB, et al. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr 2012 ; 160 : 314–319. [CrossRef] [PubMed] [Google Scholar]
  19. Brilot F, Merheb V, Ding A, et al. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011 ; 76 : 1508–1513. [CrossRef] [PubMed] [Google Scholar]
  20. Rotge JY, Guehl D, Dilharreguy B, et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry 2009 ; 65 : 75–83. [CrossRef] [PubMed] [Google Scholar]
  21. Szeszko PR, Christian C, Macmaster F, et al. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry 2008 ; 165 : 1299–1307. [CrossRef] [PubMed] [Google Scholar]
  22. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004 ; 132 : 69–79. [CrossRef] [PubMed] [Google Scholar]
  23. Rotge JY, Langbour N, Jaafari N, et al. Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry 2010 ; 67 : e37–e38. [CrossRef] [PubMed] [Google Scholar]
  24. Zarei M, Mataix-Cols D, Heyman I, et al. Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder. Biol Psychiatry 2011 ; 70 : 1083–1090. [CrossRef] [PubMed] [Google Scholar]
  25. Worbe Y, Baup N, Grabli D, et al. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cerebral Cortex 2009 ; 19 : 1844–1856. [CrossRef] [Google Scholar]
  26. Grabli D. Behavioural disorders induced by external globus pallidus dysfunction in primates. I. Behavioural study. Brain 2004 ; 127 : 2039–2054. [CrossRef] [PubMed] [Google Scholar]
  27. Karachi C, Grabli D, Baup N, et al. Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys. Mov Disord 2009 ; 24 : 1183–1192. [CrossRef] [PubMed] [Google Scholar]
  28. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 : 400–412. [CrossRef] [PubMed] [Google Scholar]
  29. Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006 ; 11 : 622–632. [CrossRef] [PubMed] [Google Scholar]
  30. Komossa K, Depping AM, Meyer M, et al. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev 2010 : CD008141. [PubMed] [Google Scholar]
  31. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry 2006 ; 51 : 407–416. [PubMed] [Google Scholar]
  32. Storch EA, Mariaskin A, Murphy TK. Psychotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep 2009 ; 11 : 296–301. [CrossRef] [PubMed] [Google Scholar]
  33. Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?. Biol Psychiatry 2002 ; 52 : 987–997. [CrossRef] [PubMed] [Google Scholar]
  34. Storch EA, Murphy TK, Goodman WK, et al. A Preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2010 ; 68 : 1073–1076. [CrossRef] [PubMed] [Google Scholar]
  35. Nuttin B, Cosyns P, Demeulemeester H, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 1999 ; 354 : 1526. [CrossRef] [Google Scholar]
  36. Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2010 ; 67 : 1061–1068. [CrossRef] [PubMed] [Google Scholar]
  37. Aouizerate B, Cuny E, Martin-Guehl C, et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 2004 ; 101 : 682–686. [CrossRef] [PubMed] [Google Scholar]
  38. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008 ; 359 : 2121–2134. [CrossRef] [PubMed] [Google Scholar]
  39. Mallet L, Mesnage V, Houeto JL, et al. Compulsions, Parkinson’s disease, and stimulation. Lancet 2002 ; 360 : 1302–1304. [CrossRef] [PubMed] [Google Scholar]
  40. Mundt A, Klein J, Joel D, et al. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci 2009 ; 29 : 2401–2412. [CrossRef] [PubMed] [Google Scholar]
  41. Baup N, Grabli D, Karachi C, et al. High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci 2008 ; 28 : 8785–8788. [CrossRef] [PubMed] [Google Scholar]
  42. Bloch MH, Landeros-Weisenberger A, Rosario MC, et al. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008 ; 165 : 1532–1542. [CrossRef] [PubMed] [Google Scholar]
  43. Mataix-Cols D, Rosario-Campos MCD, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005 ; 162 : 228–238. [CrossRef] [PubMed] [Google Scholar]
  44. Harrison BJ, Pujol J, Cardoner N, et al. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry 2013 ; 73 : 321–328. [CrossRef] [PubMed] [Google Scholar]
  45. Aouizerate B, Martin-Guehl C, Cuny E, et al. Stimulation cérébrale profonde du striatum ventral dans le traitement du trouble obsessionnel-compulsif avec dépression majeure. Med Sci (Paris) 2005 ; 21 : 811–813. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  46. Epelbaum J., Pour les tics et tocs, serait-ce SLITRK1 ? Med Sci (Paris) 2005 ; 21 : 1117. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  47. Jupille J. Le trouble déficitaire de l’attention avec hyperactivité. Med Sci (Paris) 2011 ; 27 : 318–322. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.